Table 1 Patient characteristics and preoperative data
Mannitol (n = 16) | Placebo (n = 16) | p - Value | |||
|---|---|---|---|---|---|
Age, yrs | 62 | [57, 71] | 53 | [45, 68] | 0.10 |
Height, cm | 167 | ± 10 | 170 | ± 15 | 0.58 |
Weight, kg | 74 | ± 17 | 78 | ± 17 | 0.67 |
Gender, no. (%) | 0.64 | ||||
Men | 9 | (56) | 9 | (56) | |
Women | 7 | (44) | 7 | (44) | |
Comorbidities, no. (%) | |||||
Hypertension | 15 | (94) | 15 | (94) | 1.00 |
Diabetes | 5 | (31) | 1 | (6) | 0.13 |
Insulin use | 4 | (25) | 1 | (6) | |
Non-Insulin use | 1 | (6) | 0 | (0) | |
Pulmonary | 2 | (13) | 5 | (31) | 0.39 |
Chronic Intermit. Dialysis, no. (%) | 11 | (69) | 13 | (82) | 0.70 |
Peritoneal Dialysis, no. (%) | 5 | (31) | 3 | (19) | 0.70 |
GFR, mL min−11.73 m−2 | 9.34 | (2.7) | 10.4 | (3.4) | 0.36 |
Residual Urine Output (mL 24 h− 1) | 500 | [0, 1000] | 250 | [0, 750] | 0.54 |
Patients with > 500 mL residual Urine volume, no. (%) | 8 | (50) | 9 | (56) | 0.73 |
Long-Term Medication, no. (%) | |||||
Beta Blocker | 13 | (82) | 12 | (75) | 0.67 |
ACE Inhibitors/AT1 Blocker | 8 | (50) | 9 | (56) | 0.72 |
Diuretics | 4 | (25) | 5 | (31) | 0.69 |
Preoperative Laboratory | |||||
Hemoglobin, g/dL | 11.8 | [10.7, 12.5] | 11.1 | [10.4, 12.2] | 0.70 |
Haematocrit, % | 35.7 | [32.5, 38.3] | 33.2 | [31.9, 37.4] | 0.67 |
Creatinine, mg/dL | 7.5 | [5.5, 8,7] | 8.3 | [5.5, 9.8] | 0.47 |
CRP, mg/dL | 0.2 | [0.1, 0.5] | 0.2 | [0.1, 0.7] | 0.64 |